News

The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.

More research is still needed, as this study only included data from a small number of patients, but TAVR was not linked to any severe adverse events or allergic reactions.

Joshua M. Hare, MD, FACC, FAHA, a professor of medicine, molecular and cellular pharmacology, and biomedical engineering, director of regenerative medicine, and director of the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami, and co-founder and chief science officer for the stem cell start-up Longeveron, explains the FDA trial for laromestrocel (Lomecel-B) to treat hypoplastic left heart syndrome (HLHS).

The new trial represents a potential breakthrough in the treatment of one of the most devastating congenital heart defects.

As mitral transcatheter edge-to-edge repair continues to gain momentum in the United States, a new study of CMS data examines what happens to patient outcomes when the procedure fails.

Evaluating LVDF with echocardiography or AI-powered electrocardiography can help identify individuals at an increased risk of developing atrial fibrillation, according to new data presented at the ASE 36th Annual Scientific Sessions.

Microbot Medical Liberty

The new Liberty System allows users to remotely deliver and manipulate guidewires and catheters during peripheral endovascular procedures.

The key figure from NEJM publication confirms the survival benefit of Impella CP increases year-over-year. Source: Møller J, et al. Long Term Outcomes of the DanGer Shock Trial. N Engl J Med 2025.

When patients present with STEMI-related cardiogenic shock, treatment with the Impella CP appears to make a positive impact that lasts for at least a decade.

Newsweek ranked the 50 best heart hospitals in the world

CMS has proposed a policy shift that would allow cardiac ablation procedures to be performed in ambulatory surgical centers. Arash Aryana, MD, PhD, a veteran cardiac electrophysiologist, explained why he is "extremely encouraged" by this proposal, highlighting several potential benefits. 

GE HealthCare Revolution Vibe CCTA

“FDA clearance comes at the perfect time, with guidelines being adopted clinically for cardiac CT and with positive reimbursement driving procedure growth," says Jean-Luc Procaccini, CEO, molecular imaging and CT.

Daniel Cantillon, MD, said the first leadless, dual-chamber pacing system performed very well in the Aveir dual-chamber i2i trial. #HRS #HRS23

Daniel Cantillon, MD, explained why the positive performance of Abbott's Aveir dual-chamber leadless pacemaker could lead to considerable improvements in patient care. 

collet_and_collleagues.png

Change is on the horizon for cath labs all over the world as more and more interventional cardiologists are starting to use coronary CT angiography to plan and guide PCI procedures. Patients, physicians, catheterization labs and healthcare systems all stand to gain from this growing trend.

A figure from the HRS remote monitoring consensus document on staffing challenges with remote monitoring.

The Heart Rhythm Society released a new expert consensus statement on the management of remote device clinics for implantable EP devices.

The EBR Systems WiSE leadless cardiac resynchronization therapy (CRT) system. #HRS23

Results from a pivotal clinical trial presented as a late-breaker at Heart Rhythm 2023 indicate that a new leadless pacemaker technology can deliver cardiac resynchronization therapy in patients who were not able to be treated with conventional CRT and epicardial leads.

Around the web

Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains why Congress needs to renew the Medicare geographic pay adjustments in rural areas—to make payments competitive with urban areas and help retain physicians in those communities.

GE Healthcare reports Q2 revenue growth of 3% and lower than expected tariff losses at $550 million.

Hospitals are awarded Honor Roll points if they rank in one or more of the 15 specialties that U.S. News evaluates, and in one or more of the 22 procedures or conditions for patient outcomes.